Invion (ASX:IVX) - Executive Chair & CEO, Thian Chew
Executive Chair & CEO, Thian Chew
Source: Thian Chew/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Invion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its Photosoft technology co-development deal
  • IVX and RMW Cho Group will co-develop the tumour regression treatment technology for use on cancer and related diseases
  • Invion will hand over $5 million towards the development costs, and in return receive exclusive distribution rights in the Asia Pacific region
  • The ASX-lister is hoping to raise $3 million in extra cash through a share placement plan and has received commitments for a $12 million placement
  • IVX shares have come out of a trading halt and are down 11.1 per cent at 2.4 cents each

Invion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its Photosoft technology co-development deal.

The life-sciences company came out of a trading halt today to announce the fundraise, expanded development deal and new license and distribution agreement.

Specifically, IVX and RMW Cho Group will co-develop Photosoft technology, a tumour regression treatment, for use on cancer and related diseases.

Invion will hand over $5 million towards the development costs, and in return receive exclusive distribution rights in the Asia Pacific region.

The ASX-lister already holds the exclusive Australia and New Zealand license rights to
Photosoft for certain conditions, while RMW is the technology licenser.

To help fund the new agreements, IVX has completed a $12 million placement to investors, issuing 545 million new shares at 2.2 cents each.

A free attaching option will be issued for every 2nd share subscribed for, with an issue price of 4 cents and an expiry date 18 months from the time of issue.

Additionally, the company will carry out a $3 million share purchase plan (SPP) for IVX shareholders, with new shares also priced at 2.2 cents each.

Placement shares are due to settle on November 19, while the SPP opens next Monday and closes on December 3.

After resuming trade on Tuesday, Invion shares were trading down 11.1 per cent at 2.4 cents each at 12:50 pm AEDT.

ivx by the numbers
More From The Market Online
Graphic representing wrld markets.

Duratec secures over $200M in contract awards with big energy and defence wins

Duratec has secured three new contracts across its core Energy and Defence sectors, with a combined…

Forrestania Resources advances Edna May production readiness as transformation ramps up

Forrestania Resources continues to ramp-up its transitioning to gold producer status through the restart of its…
The Market Online Video

Market Open: Anthropic in blockbuster debut, but Wall Street isn’t buying the AI story

Wall Street had a new stock-market darling on last night, but it couldn’t stop investors heading for the exits.

Turners Automotive absorbs oil shock and delivers record first half

Turners Automotive Group has retained its future earnings targets despite noting a sharp fall in vehicle…